A.-G. Gervois and B. J. Hall, J. Chem. Soc., Perkin Trans. 1, 1998,
compounds that are of interest in many pharmaceutical
products.13
2239; (d) M. H. Bolli and S. V. Ley, J. Chem. Soc., Perkin Trans. 1,
1998, 2243; (e) J. Habermann, S. V. Ley and J. S. Scott, J. Chem. Soc.,
Perkin Trans. 1, 1998, 3127; ( f ) M. Caldarelli, J. Habermann and
S. V. Ley, J. Chem. Soc., Perkin Trans. 1, 1999, 107; (g) S. V. Ley,
A. W. Thomas and H. Finch, J. Chem. Soc., Perkin Trans. 1, 1999,
669; (h) S. V. Ley, O. Schucht, A. W. Thomas and P. J. Murray,
J. Chem. Soc., Perkin Trans. 1, 1999, 1251; (i) J. Habermann,
S. V. Ley and J. S. Scott, J. Chem. Soc., Perkin Trans. 1, 1999, 1253;
(j) M. Caldarelli, J. Habermann and S. V. Ley, Bioorg. Med. Chem.
Lett., 1999, 9, 2049.
4 See for example: N. P. Ph. Buu-Hoï, E. Bisagni, R. Royer and
C. Routier, J. Chem. Soc., 1957, 625.
5 W. Davies and S. Middleton, J. Chem. Soc., 1959, 3544.
6 Z. Chen, X. Wang, W. Lu and J. Yu, Synlett, 1991, 121.
7 A. Chilin, G. Pastorini, A. Castellin, F. Bordin, P. Rodighiero and
A. Guiotto, Synthesis, 1995, 1190.
In conclusion, we have generated an array of 3-phenylbenzo-
furans 5 and 3-aminobenzofurans 6 without any chromato-
graphic purification step to demonstrate the versatility of
sequentially applying polymer-supported reagents in synthetic
sequences. Many further analogues could, in principle, be
generated by this route. All reactions produced essentially clean
products, as determined by LC-MS and NMR spectroscopy.
All intermediates could also be isolated by intercepting part of
the reaction streams and used in other synthetic programmes,
e.g. α-bromoacetophenones may be used in the synthesis of
2-hydroxy-2-aryl-1,4-benzodioxanes, which exhibit
a wide
range of biological activity,14 or in the synthesis of 4-phenyl-
thiazoles, some of which are Interleukin inhibitors.15
8 M. Fréchet, M. J. Farrel and L. J. Nuyens, J. Macromol. Sci. Chem.,
1977, 11, 507.
Acknowledgements
9 During the synthesis of 2h the polymer was added in small portions.
10 (a) S. Cacchi, L. Caglioti and E. Cernia, Synthesis, 1979, 64; (b)
A. Bongini, G. Cainelli, M. Contento and F. Manescalchi, Syn-
thesis, 1980, 143; (c) F. Rahaingoson, B. Kimpiobi-Ninafiding,
Z. Mouloungui and A. Gaset, Synth. Commun., 1992, 22, 1923;
(d) J. J. Parlow, Tetrahedron Lett., 1995, 36, 1395.
11 W. Xu, R. Mohan and M. M. Morrissey, Tetrahedron Lett., 1997,
38, 7337.
12 Longer reaction times were observed.
13 (a) V. P. Vaidya, S. B. Mahajan and Y. S. Agasimundin, Ind. J. Chem.
B, 1981, 20, 391; (b) B. Viti, D. Gianotti, R. Nannicini, R. Ricci and
V. Pestellini, J. Heterocycl. Chem., 1991, 28, 379; (c) W. W. K. R.
Mederski, M. Osswald, D. Dorsch, M. Christadler, C. J. Schmitges
and C. Wilm, Bioorg. Med. Chem. Lett., 1999, 9, 619.
14 T. Ganesh, C. Harish Kumar and G. L. David Krupadanam, Synth.
Commun., 1999, 29, 2069.
We gratefully acknowledge financial support from the Erasmus
Fellowship (to R. S.), the Stiftung Stipendien-Fonds des
Verbandes der Chemischen Industrie (Germany, Post Doctoral
Fellowship to J. H.), Cambridge Combinatorial, the BP endow-
ment and the Novartis Research Fellowship (to S. V. L.).
Notes and references
1 (a) L. A. Thompson and J. A. Ellman, Chem. Rev., 1996, 96, 555;
(b) A. Akelah and D. C. Sherrington, Chem. Rev., 1981, 81, 557;
(c) S. J. Shuttleworth, S. M. Allin and P. K. Sharma, Synthesis,
1997, 1217; (d) S. W. Kaldor and M. G. Siegel, Curr. Opin. Chem.
Biol., 1997, 1, 101.
2 (a) M. J. Suto, L. M. Gayo-Fung, M. S. S. Palanki and R. Sullivan,
Tetrahedron, 1998, 54, 4141; (b) L. M. Gayo and M. J. Suto, Tetra-
hedron Lett., 1997, 38, 513; (c) J. J. Parlow, Tetrahedron Lett., 1996,
37, 5257; (d) S. W. Kaldor, M. G. Siegel, J. E. Fritz, B. A. Dressman
and P. J. Hahn, Tetrahedron Lett., 1996, 37, 7193; (e) D. L. Flynn,
R. V. Devraj and J. J. Parlow, Curr. Opin. Drug Discovery Dev., 1998,
1, 41; ( f ) D. H. Dewry, D. M. Coe and S. Poon, Med. Res. Rev.,
1999, 19, 97; (g) S. F. Oliver and C. Abell, Curr. Opin. Chem. Biol.,
1999, 3, 299; (h) J. J. Parlow, R. V. Devraj and M. S. South, Curr.
Opin. Chem. Biol., 1999, 3, 320.
15 K. Yamaguchi, M. Yada, T. Tsuji, Y. Hatanaka, K. Goda and
T. Kobori, Bioorg. Med. Chem. Lett., 1999, 9, 957.
16 Yield determined by weight for reaction from precursor compound.
17 Purity as estimated from 1H NMR spectroscopy.
18 Masses given are obtained in the mode denoted in brackets. Mass
ions are generally [M ϩ H] or [M Ϫ H], in some case [MϩNH4] or
[MϩNa].
19 No mass ion could be observed under ES-MS conditions; EI-MS
conditions were applied.
3 (a) B. Hinzen and S. V. Ley, J. Chem. Soc., Perkin Trans. 1, 1998, 1;
(b) F. Haunert, M. H. Bolli, B. Hinzen and S. V. Ley, J. Chem. Soc.,
Perkin Trans. 1, 1998, 2235; (c) S. V. Ley, M. H. Bolli, B. Hinzen,
Communication 9/04384E
J. Chem. Soc., Perkin Trans. 1, 1999, 2421–2423
2423